Search

INFEX Therapeutics Pyrrole Acid Synthesis Patent Grant

The USPTO granted patent US12606524B2 to INFEX Therapeutics Limited for a novel method of synthesizing pyrrole acid derivatives that function as metallo-β-lactamase inhibitors. These compounds are designed for use in combination with carbapenem antibacterial agents to treat bacterial infections. The patent claims priority to application 18246777, filed October 6, 2021, and contains 3 claims under CPC classification C07D 207/48.